Integra LifeSciences revenue rises 3.1% in 2019, hits $1.52B: 5 details

Written by Alan Condon | February 21, 2020 | Print  |

Integra LifeSciences posted $395.1 million in reported revenue for the fourth quarter, an increase of 3.1 percent year-over-year.

Five things to know:

1. Reported revenue for full-year 2019 increased 3.1 percent to $1.52 billion, compared to 2018.

2. Global neurosurgery sales increased 7 percent year-over-year to $183.1 million.

3. Total orthopedics and tissue technology revenues rose 1.6 percent on an organic basis to $136 million, compared to the same period for the prior year.

4. For 2020, the company anticipates full-year adjusted earnings per diluted share to be in the range of $3 to $3.05.

5. Integra plans to grow its OTT line this year to "become a market leader in regenerative technologies," Peter Arduini, president and CEO at Integra, said during the fourth quarter earnings call, transcribed by The Motley Fool.

More articles on devices:
Stryker ranks No. 8 in Fortune's 100 best workplaces
Wuhan neurosurgeon, hospital director dies from coronavirus, death toll rises to 1,800+
Medtronic reports spine revenue up 3%, hurt by low BMP sales: 7 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers